Excess Reinsurance

Excess Reinsurance Solutions

A single catastrophic claim can strain even a well-managed health plan’s balance sheet. We offer excess of loss reinsurance, gene therapy protection, and cost containment solutions that help Blue Cross Blue Shield plans reduce risk exposure, increase actuarial credibility, and gain the collective buying power of the Blue System.

Graphs and charts graphic

What Is Excess Reinsurance?

Excess reinsurance — also called excess of loss reinsurance — protects a health plan from the cost of individual claims that exceed a set retention amount. Instead of absorbing a catastrophic claim alone, a plan cedes the risk above that retention to a reinsurer, capping its exposure and stabilizing its balance sheet. For Blue Cross Blue Shield plans, BCS Financial pools this risk across the Blue System, turning the collective scale of the Blue plans into negotiating leverage and actuarial credibility that no single plan could reach alone.

BCS has provided risk solutions to Blue Cross Blue Shield plans for more than 75 years, supporting a network of more than 22 million insured customers across all 50 states.

Over 75 years providing innovative solutions

Over 75 years providing innovative solutions

22 million insured customers

22 million
insured customers

A (Excellent) rating by A.M. Best Company

A (Excellent) rating by A.M. Best Company

Licensed in all 50 states with our affiliates

Licensed in all 50 states with our affiliates

Excess Reinsurance Solutions from BCS

Three complementary ways to protect a health plan’s balance sheet, built for Blue Cross Blue Shield plans and the partners that support them.

Umbrella covering a green heart icon and orange check icon

Excess of Loss

For Blue Cross Blue Shield plans. Protection against disruption from large, unpredictable high-cost medical claims, leveraging the collective scale of BCBS companies to reduce volatility and strengthen actuarial credibility.

gene therapy stop loss GT icon

Gene Therapy Reinsurance

For health plans. A reinsurance pool product that covers gene therapy ingredient costs, protecting plans against large, catastrophic claims — with back-end management services included.

Cost Containment Solutions

For plans and employers. Partnerships with specialty vendors and service providers supporting clinical intervention and cost-saving initiatives that manage exposure to high-cost claims.

Who We Serve

AudienceFit
Blue Cross Blue Shield PlansExcess of loss reinsurance that caps exposure to catastrophic individual claims and pools risk across the Blue System for greater actuarial credibility and negotiating power.
Plans Managing Gene Therapy ExposureDedicated gene therapy reinsurance alongside excess of loss coverage, protecting against $2M–$4M single-treatment claims.
Plans Seeking Cost SavingsAccess to BCS’s cost containment vendor network for clinical intervention and claims cost reduction.
Brokers & ConsultantsGuidance structuring excess reinsurance programs for Blue plan clients, alongside stop loss and cost containment options.

How It Works

1. Assess your risk profile

Share your plan’s claims experience, retention levels, and risk tolerance.

2. Structure your program

Choose excess of loss for broader coverage, or gene therapy for specific gene therapy ingredient only coverage for your plan.

3. Strengthen your balance sheet

Cap catastrophic claim exposure and gain the collective negotiating power of the Blue System.

Excess Reinsurance FAQs

Excess reinsurance (or excess of loss reinsurance) protects a health plan from the cost of individual claims above a set retention amount, capping the plan’s exposure to catastrophic losses.

Excess reinsurance is typically structured plan-to-plan — for example, between BCS and a Blue Cross Blue Shield company — while stop loss is typically purchased by self-funded employers. Both work the same way: capping claim exposure above a retention point.

Actuarial credibility refers to how statistically reliable a claims data set is for pricing and reserving. Pooling claims experience across multiple Blue plans creates a larger, more reliable base than any single plan could generate alone.

BCS offers dedicated gene therapy reinsurance that can complement excess of loss coverage, protecting against $2M–$4M single-treatment claims.

BCS acquired Medical Risk Managers (MRM) to expand its RiskNavigator solution set, broadening the underwriting and insurance capabilities available to Blue plans.

Strengthen Your Plan’s Balance Sheet Before the Next Large Claim

Talk with a BCS specialist about excess of loss and gene therapy reinsurance options for your plan.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
For your protection, please do not include policy numbers or other health or financial information in this request. If this information is required to complete your request, someone from BCS will be in touch.

Excess Reinsurance Insights & Resources